BioCentury
ARTICLE | Company News

Astralis, SkyePharma deal

December 20, 2004 8:00 AM UTC

SKP will buy 11.2 million ASTR shares from former directors in exchange for 6 million shares of SKP. The agreement is subject to the negotiation of definitive agreements and the appointment of additio...